These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6086772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
    Ashley RL, Corey L.
    J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
    Gold D, Ashley R, Solberg G, Abbo H, Corey L.
    J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins.
    Ashley R, Mack K, Critchlow C, Shurtleff M, Corey L.
    J Med Virol; 1988 Mar; 24(3):309-19. PubMed ID: 2835427
    [Abstract] [Full Text] [Related]

  • 7. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.
    Kahlon J, Lakeman FD, Ackermann M, Whitley RJ.
    J Clin Microbiol; 1986 Apr; 23(4):725-30. PubMed ID: 2422204
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections.
    Frenkel L, Pineda E, Garratty E, Fall H, Dillon M, Bryson Y.
    J Infect Dis; 1989 May; 159(5):845-50. PubMed ID: 2540245
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R, Mou SW, Zaia JA.
    J Med Virol; 1985 Jun; 16(2):147-62. PubMed ID: 2409225
    [Abstract] [Full Text] [Related]

  • 12. Recurrences after first episodes of genital herpes in patients treated with topical acyclovir cream.
    Barton IG, Kinghorn GR, Rowland M, Jeavons M, Al-Omer LS, Potter CW.
    Antiviral Res; 1984 Oct; 4(5):293-300. PubMed ID: 6517563
    [Abstract] [Full Text] [Related]

  • 13. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
    Molin L, Ruhnek-Forsbeck M, Svennerholm B.
    Scand J Infect Dis Suppl; 1991 Oct; 80():33-9. PubMed ID: 1666444
    [Abstract] [Full Text] [Related]

  • 14. Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus.
    Erlich KS, Hauer L, Mills J.
    J Med Virol; 1988 Sep; 26(1):33-9. PubMed ID: 3183633
    [Abstract] [Full Text] [Related]

  • 15. Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection.
    Kawana T, Hashido M, Koizumi Y.
    Microbiol Immunol; 1995 Sep; 39(10):795-9. PubMed ID: 8577270
    [Abstract] [Full Text] [Related]

  • 16. Genital herpes simplex infections: effect of asymptomatic shedding and latency on management of infections in pregnant women and neonates.
    Yeager AS.
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):53s-56s. PubMed ID: 6330222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.
    Lee FK, Coleman RM, Pereira L, Bailey PD, Tatsuno M, Nahmias AJ.
    J Clin Microbiol; 1985 Oct; 22(4):641-4. PubMed ID: 3001136
    [Abstract] [Full Text] [Related]

  • 19. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus.
    Bryson YJ.
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052
    [Abstract] [Full Text] [Related]

  • 20. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC, Day LM, Crowley JJ, Meyers JD.
    J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.